Posts Tagged ‘pharmaceutical’

« Older Entries |

Five former mayors of Toronto on why it is time for the city to decriminalize simple drug possession

Saturday, June 19th, 2021

As the death toll mounts, in Toronto and elsewhere in Canada, it is crystal clear that the criminalization of drug use has been a costly public policy mistake that must be remedied. Criminalization is costing human lives at a merciless pace. Racialized minorities and the poor are disproportionately arrested, convicted and incarcerated for possession. And taxpayers pay the costly policing, courts and corrections bills.

Tags: , , , ,
Posted in Health Debates | No Comments »

Governments paid billions to help develop COVID-19 vaccines — so why is Big Pharma charging us billions more for the vaccines we helped create?

Thursday, June 3rd, 2021

If we think of war profiteers as being lower than a snake’s belly, what are we to make of the drug industry’s pandemic profiteers? … Canada, like other government funders in this global crisis, is not expecting to recover its costs in funding COVID-related medicine…  governments that fund research that is used in lucrative commercial drug production must demand a return on their investment. 

Tags: , , , , , ,
Posted in Policy Context | No Comments »

‘Not vaccine hesitancy but inequity.’ Organizers take us inside Toronto’s northwest pop-ups where lines form everyday at 5 a.m.

Tuesday, May 4th, 2021

… thousands lined up in rain and snow make it clear that low vaccination rates in these communities aren’t products of vaccine hesitancy. Rather, the situation unfolding has everything to do with structural inequities that starve communities of key resources, and in this case, life saving vaccines in the midst of a deadly pandemic… If vaccines are made accessible in trusted spaces, through trusted relationships, people will come.

Tags: , , , ,
Posted in Health Delivery System | No Comments »

‘It’s time’: Local moms laud area senator’s drug-decriminalization bill

Saturday, May 1st, 2021

Former OPP commissioner leading the charge for a national strategy; ‘These are people with health issues who need treatment, not jail time’… the opioid crisis continues to devastate people and families from all walks of life. Boniface noted there were 1,517 apparent opioid toxicity deaths in Ontario in 2019… In 2019, about 75 per cent of all opioid-poisoning deaths involved fentanyl. “If that’s not enough to start a conversation, I don’t know what is”

Tags: , , , , ,
Posted in Child & Family Policy Context | No Comments »

Throwing money at Big Pharma won’t guarantee vaccine supply

Thursday, April 8th, 2021

Now we’re poised to give Sanofi hundreds of millions of taxpayer dollars in the hope of ensuring a future vaccine supply… If we really want a biotech company we can rely on and that doesn’t hold a gun to our head, we should spend our money creating an enterprise that we actually own and control – a little secret learned by Cuba and, decades earlier, by the brilliant Canadians who created Connaught.

Tags: , , , , , ,
Posted in Health Debates | No Comments »

Canada needs the Connaught model of domestic vaccine production

Saturday, March 20th, 2021

A properly restored Canadian global powerhouse in vaccines would improve on the current world patchwork of players focused on discovery, clinical trials, safe packaging, mass production and a dozen other disciplines, layered over by conflicting priorities of national governments. That model conflicts with Ottawa’s current $1-billion national vaccine strategy.

Tags: , , ,
Posted in Health Policy Context | No Comments »

When will the Liberal government keep its promises on national pharmacare?

Saturday, March 6th, 2021

Canadians have waited for decades for universal pharmacare. With the onset of the COVID-19 pandemic, they cannot wait any longer… The 2021 federal budget is just around the corner. If the government’s rejection of C-213 was because it was written on the terms of an opposition party and not their own, this may be one of the last opportunities for the prime minister to make good on his public support for universal, public pharmacare.

Tags: , , , , , , , ,
Posted in Health Policy Context | No Comments »

Compulsory licensing would allow Ottawa to authorize generic copies of the COVID-19 vaccines

Friday, February 5th, 2021

compulsory licensing would eliminate the need for constant negotiation. The government would make its decision and that would be that. The drug giants would be furious. Pfizer and Moderna might refuse to honour their pledges. They might cut back promised shipments of the vaccine.
But they are doing that anyway. And the government has been unable to use the usual methods of contract compliance to stop them. Compulsory licensing provides government with a workable alternative…

Tags: , , , , ,
Posted in Health Policy Context | No Comments »

A broader vision of public health

Wednesday, January 27th, 2021

If we learn anything from COVID-19, it should be that we need a more comprehensive version of public health that acts on what we know about the social determinants of well-being… Here’s our three-step plan. 1. Identify the contours of an integrated, coherent vision of public health… 2. Co-ordinate the wider public health vision across political jurisdictions… 3. Work from the ground up to uncouple “health” from “health care.” 

Tags: , , , , , , ,
Posted in Health Policy Context | No Comments »

NDP and Greens Push Trudeau to Answer Vancouver’s Call to Decriminalize Drugs

Monday, December 28th, 2020

The MPs want Hajdu to use her authority under Section 56 of the act, which grants the health minister the power to issue an exemption from any part of the legislation “for a medical or scientific purpose or is otherwise in the public interest.” … to take the supply “out of the hands of criminals and remove the stigmatization, and ensure that people get access to safe, regulated, properly packaged products. And we need to substantially beef up our prevention, education and, most importantly, treatment options for substance users.

Tags: , , , ,
Posted in Health Policy Context | No Comments »

« Older Entries |